Computational Pathology Market Summary

The global computational pathology market size was estimated at USD 682.48 million in 2024 and is projected to reach USD 1,447.62 million by 2033, growing at a CAGR of 9.0% from 2025 to 2033. This growth is attributed to the rising integration of machine learning and artificial intelligence (AI) technologies across diagnostic workflows, the increasing demand for advanced digital solutions that enable faster and more precise diagnoses, the rising prevalence of chronic conditions requiring detailed pathological evaluation, and the expanding investments by healthcare companies that are developing innovative and more efficient computational tools.

The computational pathology market is predominantly propelled by the increasing incidence of chronic diseases, notably cancer. The growing burden of cancer cases worldwide is encouraging pathologists to rely on digital and computational tools that can help analyze large datasets and generate insights required for personalized treatment strategies. As a result, digital pathology is becoming a preferred option among pathologists, as it not only speeds up the diagnostic process but also enhances accuracy and assists in therapeutic decision-making to improve patient outcomes. For instance, according to a study published in the Journal of Pathology in August 2023, the use of deep learning and artificial intelligence (AI) algorithms to analyze and interpret histopathology images offers significant improvements in diagnostic precision and operational efficiency, particularly in cancer detection and prognosis.

Key Market Trends & Insights

• North America dominated the global computational pathology market with a share of 45.7% in 2024, driven by advanced healthcare infrastructure, high adoption of digital technologies, and increased spending on automated diagnostic solutions.
• Computational pathology market in the U.S. accounted for the largest share in 2024 due to strong regulatory support, a high concentration of technology developers, and the presence of well-established healthcare systems that readily incorporate innovative diagnostic tools.
• By component, the software segment held the largest market share of 66.5% in 2024, supported by rising demand for digital pathology software, image analysis platforms, workflow management systems, and AI-driven diagnostic tools.
• By application, the disease diagnosis segment held the dominant market share in 2024, as diagnostic accuracy, faster sample interpretation, and personalized treatment planning continue to be top priorities in modern healthcare.
• By technology, the machine learning (ML) segment held the largest revenue share in the computational pathology market in 2024, reflecting its central role in image classification, pattern recognition, anomaly detection, and decision support.
• By end use, hospitals and diagnostic labs segment held the dominant market share in 2024, largely due to the high volume of patient tests, the need for efficient workflow management, and the growing reliance on digital pathology systems for routine and specialized diagnostics.

Order a free sample PDF of the Computational Pathology Market Intelligence Study, published by Grand View Research.

Market Size & Forecast

• 2024 Market Size: USD 682.48 Million
• 2033 Projected Market Size: USD 1,447.62 Million
• CAGR (2025-2033): 9.0%
• North America: Largest market in 2024
• Asia Pacific: Fastest growing market

Key Companies & Market Share Insights

Key companies are adopting strategies such as mergers and acquisitions, product and service launches, agreements, joint ventures, collaborations, and expansion to strengthen their position in the market.

Key Players

• Leica Biosystems Nussloch GmbH (subsidiary of Danaher)
• Hamamatsu Photonics K.K.
• Koninklijke Philips N.V.
• Olympus Corporation
• Hoffmann-La Roche Ltd.
• Aiforia/ Aiforia Technologies PLC
• Epredia (3DHISTECH Ltd.)
• Visiopharm A/S
• Proscia Inc.
• Mindpeak GmbH
• Akoya Biosciences, Inc. (a Quanterix company)
• Paige AI, Inc.
• CellaVision
• aetherAI
• Qritive
• IBEX (IBEX MEDICAL ANALYTICS) Nucleai, Inc.
• Nucleai, Inc.

Explore Horizon Databook – The world's most expansive market intelligence platform developed by Grand View Research.

Conclusion

The computational pathology market is positioned for substantial expansion as healthcare providers increasingly adopt digital and AI-enabled diagnostic tools. Growing demand for rapid and accurate disease detection, particularly in oncology, continues to strengthen the need for advanced computational platforms. With strong contributions from software advancements, machine learning innovations, and expanding use across hospitals and diagnostic labs, the industry will continue to evolve. Rising investments, improved technological capabilities, and global efforts to enhance diagnostic precision will collectively support long-term market growth and reinforce the importance of computational pathology in modern healthcare.